Community Care Market News (News) July 1998The costs of new drug therapies which are used to treat patients with Alzheimer’s disease (AD) may be negated if they are successful enough to delay admittance to institutional care even for a few weeks. Alzheimer’s Disease in the UK – Burden of Disease and Future Care, claims that…
Membership Required
You must be a CM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
